Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125326971 | 12532697 | 1 | I | 20160614 | 20160620 | 20160706 | 20160706 | EXP | US-ABBVIE-16K-163-1657121-00 | ABBVIE | 48.83 | YR | F | Y | 0.00000 | 20160706 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125326971 | 12532697 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 1056662 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | ||||||
125326971 | 12532697 | 2 | SS | TOPIRAMATE. | TOPIRAMATE | 1 | Unknown | N | UNKNOWN | 0 | |||||||||
125326971 | 12532697 | 3 | C | RANITIDINE. | RANITIDINE | 1 | 0 | ||||||||||||
125326971 | 12532697 | 4 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
125326971 | 12532697 | 5 | C | BUSPIRONE | BUSPIRONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
125326971 | 12532697 | 6 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
125326971 | 12532697 | 7 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
125326971 | 12532697 | 8 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
125326971 | 12532697 | 9 | C | LOVASTATIN. | LOVASTATIN | 1 | 0 | ||||||||||||
125326971 | 12532697 | 10 | C | TIZANIDINE. | TIZANIDINE | 1 | 0 | ||||||||||||
125326971 | 12532697 | 11 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 0 | ||||||||||||
125326971 | 12532697 | 12 | C | NITROFURANTOIN. | NITROFURANTOIN | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125326971 | 12532697 | 1 | Ankylosing spondylitis |
125326971 | 12532697 | 2 | Headache |
125326971 | 12532697 | 3 | Gastrooesophageal reflux disease |
125326971 | 12532697 | 4 | Fluid retention |
125326971 | 12532697 | 5 | Anxiety |
125326971 | 12532697 | 6 | Neuropathy peripheral |
125326971 | 12532697 | 7 | Ankylosing spondylitis |
125326971 | 12532697 | 8 | Depression |
125326971 | 12532697 | 9 | Blood cholesterol increased |
125326971 | 12532697 | 10 | Tremor |
125326971 | 12532697 | 11 | Bladder disorder |
125326971 | 12532697 | 12 | Prophylaxis urinary tract infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125326971 | 12532697 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125326971 | 12532697 | Amnesia | |
125326971 | 12532697 | Angle closure glaucoma | |
125326971 | 12532697 | Headache | |
125326971 | 12532697 | Hydrocephalus | |
125326971 | 12532697 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125326971 | 12532697 | 1 | 20151209 | 0 | ||
125326971 | 12532697 | 2 | 20160621 | 0 |